Drugs / 2',3'-dideoxyinosine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00001267 | Oct 1990 → Apr 2000 | AIDS, AIDS related complex | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 2',3'-dideoxyinosine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00001267 ↗ |
| Known as | ddI | “This study will involve therapy of patients with AIDS or ARC with two of these agents, AZT and 2', 3'-dideoxyinosine (ddI), which have different toxicity profiles, over a...” NCT00001267 ↗ |